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Abstract
An increasing number of studies indicate that dairy products, including whey protein, alleviate several disorders of the
metabolic syndrome. Here, we investigated the effects of whey protein isolate (whey) in mice fed a high-fat diet
hypothesising that the metabolic effects of whey would be associated with changes in the gut microbiota composition.
Five-week-old male C57BL/6 mice were fed a high-fat diet ad libitum for 14 weeks with the protein source being either
whey or casein. Faeces were collected at week 0, 7, and 13 and the fecal microbiota was analysed by denaturing gradient
gel electrophoresis analyses of PCR-derived 16S rRNA gene (V3-region) amplicons. At the end of the study, plasma samples
were collected and assayed for glucose, insulin and lipids. Whey significantly reduced body weight gain during the first four
weeks of the study compared with casein (P,0.001–0.05). Hereafter weight gain was similar resulting in a 15% lower final
body weight in the whey group relative to casein (34.061.0 g vs. 40.261.3 g, P,0.001). Food intake was unaffected by
protein source throughout the study period. Fasting insulin was lower in the whey group (P,0.01) and glucose clearance
was improved after an oral glucose challenge (P,0.05). Plasma cholesterol was lowered by whey compared to casein
(P,0.001). The composition of the fecal microbiota differed between high- and low-fat groups at 13 weeks (P,0.05)
whereas no difference was seen between whey and casein. In conclusion, whey initially reduced weight gain in young
C57BL/6 mice fed a high-fat diet compared to casein. Although the effect on weight gain ceased, whey alleviated glucose
intolerance, improved insulin sensitivity and reduced plasma cholesterol. These findings could not be explained by changes
in food intake or gut microbiota composition. Further studies are needed to clarify the mechanisms behind the metabolic
effects of whey.
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Introduction
The prevalence of obesity is increasing dramatically in both
Western and developing countries [1]. Therefore nutritional
approaches to prevent and control obesity are crucial to fight
the epidemic of obesity-related disorders, such as type 2 diabetes
and cardiovascular diseases.
Over the last decade, several studies have indicated that dairy
consumption has beneficial effects on life style diseases. Elwood
and colleagues [2] reported an overall survival advantage from the
consumption of milk and dairy foods based on meta-analyses of
several studies. Epidemiological studies consistently show that
dairy-product intake is inversely related to obesity, as determined
by body mass index [3–5], and the metabolic syndrome [6–8]
which is defined as a cluster of risk factors for cardiovascular
disease and type 2 diabetes [9,10]. Conclusions from intervention
studies are, however, rather inconsistent, as some studies
demonstrate a beneficial effect of dairy product intake on the
amount of body fat [11,12] whereas other studies show no effect
on body weight and other parameters related to the metabolic
syndrome [13,14]. Various milk components have been suggested
to be beneficial, including the milk proteins whey and casein. Both
are high quality proteins and contain all the essential amino acids
[15]. Recent studies indicate that whey protein in particular
reduces body weight and improves insulin sensitivity in rodent
models [16–19] as well as in humans [20–22].
Within the last years, it has become increasingly evident that the
gut microbiota (GM) plays an important role in conditions such as
obesity and type 2 diabetes [23–25]. Diet influences the
composition of the GM; especially high-fat diet [26,27] and non-
digestible carbohydrates [28], named prebiotics, are known to
have a strong impact on GM. Only a few studies have been
published regarding the influence of dietary protein quality or
quantity on the GM. Yet, whey protein has been shown to increase
the quantity of fecal lactobacilli and bifidobacteria when
compared with casein in a study by Sprong et al. [29]. Thus,
whey protein potentially influences metabolic health, and a
possible mechanism may be through changes in the GM. In this
study, we therefore investigated the metabolic effects of whey
protein compared with casein in mice fed a high-fat diet, and we
hypothesised that the effects of whey protein on the various
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hallmarks of the metabolic syndrome would be associated with
changes in the GM composition.
Results
Body weight, feed efficiency, and organ weights
Replacement of casein with whey in the diet markedly
decreased weight gain during the early weeks of the study. After
the first week of diet intervention, mice on high-fat (HF) whey had
gained 1.060.3 g of body weight compared to 4.160.3 g in the
HF casein group and 2.960.3 g in the low fat control (LF casein)
(HF whey vs. HF casein: P,0.001; HF whey vs. LF casein:
P,0.001). The difference in weekly weight gain declined the
following three weeks and thereafter the weight gain was similar
between the two HF groups. At the end of the study, this resulted
in a significantly lower final body weight in the HF whey group
(34.061.0gram) compared to the HF casein group
(40.261.3gram) (P,0.001) (Figure 1 and Table 1).
While cumulated energy intake did not differ significantly
between HF whey and HF casein group, feed efficiency was
reduced in the HF whey group compared to HF casein during the
first four weeks (P,0.001) but not during the last 10 weeks
(Table 1). Food intake was not at any time point significantly lower
in HF whey than in HF casein, indicating that palatability was not
compromised when replacing casein with whey (data not shown).
Whey reduced the relative inguinal (subcutaneous) fat pad
weight compared to casein (P,0.05, HF casein vs. HF whey) while
the relative weights of the epididymal and perirenal/retroperito-
neal fat pad (intra-abdominal fat) were unaffected by protein
source (Table 2). Consequently, body fat percentage, as estimated
by the total amount of measured fat divided by body weight, was
not significantly different between HF casein and HF whey (data
not shown). Absolute muscle weights (Table 2) and liver weights
(data not shown) did not differ between groups.
Plasma lipids
Fasting plasma total cholesterol was significantly lowered by
whey (P,0.001, HF casein vs. HF whey) to a concentration not
different from the LF casein group whereas fasting plasma
triacylglycerols and non-esterified fatty acids were similar in all
groups (Table 3).
Glycemic parameters
Fasting blood glucose prior to glucose administration during the
OGTT was significantly lower in the HF whey group compared to
HF casein (P,0.001). Even though blood glucose rose to a
significantly higher level at time = 30 minutes (P,0.05), blood
glucose was significant lower in the HF whey group compared to
the HF casein group at time = 90 (P,0.01), 120 (P,0.01), and
180 (P,0.05) minutes after glucose administration (Figure 2).
While AUC calculations did not reveal any significant difference
between HF casein and HF whey due to the higher peak of HF
whey at time = 30 (data not shown), ANOVA Repeated
Measurements revealed a significant difference in blood glucose
curves between HF casein and HF whey (P,0.05) (Figure 2). At
Figure 1. Body weight during 14 weeks of dietary intervention.
The body weight of HF whey was lower than HF casein at all times after
week 0 (P,0.05). The weekly weight gain was lower in HF whey than HF
casein at week 1, 2, and 4 (*, P,0.05). Data is presented as mean 6SEM
and compared by one-way ANOVA. HF casein, high-fat diet with casein
(n = 15), HF whey, high-fat diet with whey protein isolate (n = 15), LF
casein, low-fat diet with casein (n = 10).
doi:10.1371/journal.pone.0071439.g001
Table 1. Food intake and feed efficiency.
HF casein HF whey LF casein
Weight gain (g/cage) 0–4 weeks 49.161.5a 24.363.9b 35.362.1a,b
Energy intake (kJ/cage) 0–4 weeks 6723.3681.0a,b 7479.16344.1a 5860.36283.5b
Feed efficiency (mg/kJ) 0–4 weeks 7.3160.24a 3.2460.44b 6.0160.06a
Weight gain (g/cage) 4–14 weeks 74.167.0a 68.060.2a 38.562.1b
Energy intake (kJ/cage) 4–14 weeks 15060.16685.3 15381.861035.0 13681.0647.2
Feed efficiency (mg/kJ) 4–14 weeks 4.9060.26a 4.4660.30a 2.8160.14b
Results not sharing a common superscript differ significantly (P,0.05).
doi:10.1371/journal.pone.0071439.t001
Table 2. Body composition after 14 weeks of dietary
intervention.
HF casein HF whey LF casein
Inguinal fat (mg/g) 23.8661.85a 18.3861.64b 13.6261.10b
Epididymal (mg/g) 30.4561.36a 30.6162.33a 18.5861.12b
Perirenal and retroperitoneal
fat (mg/g)
10.0960.30a 9.5260.76a 6.4760.44b
Gastrocnemius and soleus
muscles (mg)
15465 15665 15965
Quadriceps muscles (mg) 18068 18268 191612
Results not sharing a common superscript differ significantly (P,0.05).
doi:10.1371/journal.pone.0071439.t002
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the end of the study, fasting insulin was significantly reduced by
whey feeding (P,0.01) and fasting plasma glucose was also
reduced although it failed to reach statistical significance (P,0.10,
HF casein compared to HF whey) (Table 3). Consequently, insulin
sensitivity in the HF whey group, as estimated by the Quantitative
Insulin Sensitivity Check Index (QUICKI), was markedly
improved compared with HF casein (P,0.01) (Table 3). HbA1c
was not significantly different between any of the three groups
(Table 3).
Fecal microbiota
The composition of the GM, analyzed by denaturing gradient
gel electrophoresis (DGGE), was similar between all groups at the
beginning of the experiment and after 7 weeks of diet intervention
(data not shown). After 13 weeks there was a significant difference
between high- and low-fat diets (P,0.05) while protein source did
not affect GM composition (Figure 3).
Discussion
In this study, we showed that whey reduces body weight gain,
alleviates glucose intolerance, improves insulin sensitivity and
reduces plasma cholesterol in mice fed a high-fat diet. Interest-
ingly, whey had an acute but not chronic effect on weight gain.
After the first week the effect gradually ceased but the weight
difference persisted throughout the study period. During the initial
weeks, even the control group on a low-fat diet gained more
weight than the mice fed a high-fat diet with whey. While many
studies have shown a reductive effect of whey on final body weight
the time course of the effect is typically not discussed. As estimated
by the published graphs of body weight gain in related studies,
timing is a factor that should be taken into consideration when
exploring the mechanisms of whey-reduced body weight gain. As
an example, female whey-fed C57BL/6J mice did not gain weight
during the first 10 days of the high-fat diet intervention while the
high-fat control mice immediately gained weight [18]. In another
mouse study, whey reduced weight gain gradually during the diet
intervention [30]. In one rat study, the most profound reduction in
body weight gain by whey was seen during the first week of the
diet intervention when whey protein was compared to red meat
protein [19] while Royle et al. [17] reported reduced weight gain
by whey compared to casein during both early and later weeks of
the intervention. Thus, published data indicate that whey protein
feeding requires a couple of weeks of adaption before normal body
weight gain is re-established.
Accumulated food intake was neither reduced by whey in our,
nor in the above-mentioned studies. Our data does not suggest
that changes of the composition of the GM are responsible for the
reduced body weight gain either as no difference was found on the
DGGE between casein and whey fed mice. However, early GM
changes cannot be ruled out completely as faeces was sampled
after seven and thirteen weeks of intervention where body weight
gain was unaffected by protein source. The scarcity of studies on
the effect of dietary protein on faecal GM composition might be
explained by an efficient absorption of protein in the small
intestine causing possible changes in the proximal gut to be non-
detectable when the intestinal content reaches the rectum.
As both whey and casein are high-quality protein sources it
seems unlikely that the reduced weight gain of whey-fed mice is
due to suboptimal nutrition. However, the absorption kinetics of
whey and casein are rather different. Whey proteins enter the
small intestine as intact proteins and are relatively quickly
absorbed. Casein forms a clot in the acid environment of the
stomach which causes a slower absorption [31]. One explanation
of the acute effect of whey on weight gain could be that the
postprandial amino acid delivery to the liver is too rapid to be fully
utilised by the body, at least until a certain adaptation has
occurred. This explanation is supported by the results of a study by
Lacroix et al. [32] where healthy volunteers received a meal with
different [15N]-labelled milk protein fractions. During the follow-
ing eight hours plasma amino acids, proteins, urea and urinary
urea were measured. Milk soluble protein isolate (whey protein)
caused a high but transient hyperaminoacidemia which concom-
itantly lead to an earlier and higher transfer of dietary nitrogen to
urea when compared to casein and total milk protein. Total
postprandial deamination was increased by whey protein indicat-
ing a higher degree of ‘‘protein-waste’’ and therefore a suboptimal
ability to support (muscle) growth. These findings in humans are
based on a single meal whereas the mice in our study were fed ad
libitum. Mice and rats do however tend to eat in a meal-like
pattern with three larger meals eaten during the dark phase
[33,34]. Catabolism of amino acids is an energy-consuming
Table 3. Plasma lipid profile and glycemic parameters.
HF casein HF whey LF casein
Cholesterol (mM) 4.4960.14a 3.6660.15b 3.4460.15b
Triacylglycerols (mM) 0.9260.05 0.9660.05 0.9560.04
Non-esterified fatty acids
(mM)
1.6560.10 1.7360.10 1.8060.10
Glucose (mM) 16.8860.69a 14.7560.68a,b 12.8960.68b
HbA1c (%) 4.3160.04 4.3960.04 4.2760.06
Insulin (pM) 762.16149.6a 318.4633.1b 221.0629.6b
QUICKY 0.2360.005a 0.2560.004b 0.2660.004b
Results not sharing a common superscript differ significantly (P,0.05).
HbA1c, glycated haemoglobin. QUICKI, Quantitative Insulin Sensitivity Check
Index.
doi:10.1371/journal.pone.0071439.t003
Figure 2. Oral glucose tolerance test after 12 weeks of dietary
intervention. Glucose clearance was significantly improved by whey
(P,0.05, HF casein compared to HF whey, Repeated Measurements
ANOVA and Tukey’s Post Hoc test). Asterisks indicate time points were
blood glucose in HF whey is significantly lower than in HF casein (one-
way ANOVA). * P,0.05, ** P,0.01, *** P,0.001 in comparison to HF
casein. Data is presented as mean 6SEM. HF casein, high-fat diet with
casein (n = 15), HF whey, high-fat diet with whey protein isolate (n = 15),
LF casein, low-fat diet with casein (n = 10).
doi:10.1371/journal.pone.0071439.g002
Metabolic Effects of Whey Protein in Mice
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process [35,36], hence an increased influx of amino acids into the
urea cycle as a consequence of hepatic amino acid overload after
whey intake could therefore explain the decreased feed efficiency
at week 0–4 seen in the present study. After a couple of weeks, a
physiological adaptation seems to occur and the amino acids of
whey are apparently more successfully utilized for growth in
consistency with the similar weight gain during the last period of
the study and the similar final muscle mass to HF casein. In our
study the mice were rather young (five weeks old) and displaying a
high growth rate when placed on the test diets which might have
made them even more susceptible to a possible decreased
utilisation of whey protein. In the study by Lacroix et al. [32]
total milk protein ingestion resulted in the best dietary nitrogen
utilisation suggesting that the natural combination of casein and
whey in milk is the most beneficial for growth (80:20 ratio in cow’s
milk).
Irrespective of the similar weight gain during the last ten weeks
of the study and the same relative amount of intra-abdominal fat,
whey significantly alleviated other parameters of the metabolic
syndrome compared to casein at the end of the study. Glucose
intolerance and insulin resistance were attenuated in agreement
with the findings in female C57BL/6 mice by Shertzer et al. [18].
Fasting plasma cholesterol was also lowered by whey consistent to
the results of a human dietary intervention study [21]. These
beneficial effects of whey could not be explained by changes in
feed efficiency or GM composition in our study. Whey differs,
however, from casein in other ways than absorption kinetics.
While casein is a well-defined pure protein, whey consists of a
heterogeneous group of soluble proteins that exhibits some
variation depending on the manufacturing process. For instance,
glycomacropeptide, a whey protein which has been shown to
improve several metabolic parameters as investigated by Royle et
al. [17], is removed by ion exchange and therefore is not found in
the diet tested in the present study. Generally, whey is rich in
branched-chain amino acids including leucine which have been
shown to decrease obesity, improve glycemic control and decrease
plasma cholesterol in high-fat fed C57BL/6J mice [37]. Casein is
rich in phosphor which might influence mineral absorption when
caseino-phosphopeptides are formed during casein digestion.
Since calcium binds to the caseino-phosphopeptides [38] there
might be less free calcium available for synthesis of intestinal fat-
calcium salts, leading to a smaller fat excretion and thus higher
apparent fat absorption, in casein-fed mice compared to whey-fed
mice as suggested by Pilvi et al. [30]. Thus, the higher level of
branch-chained amino acid and the potentially decreased fat
absorption might add to the explanation of the metabolic effects of
Figure 3. Fecal microbiota profile after 13 weeks of dietary intervention. Principal Component Analysis Plot based on Denaturing Gradient
Gel Electrophoresis profiles of 16S rRNA gene PCR-derived amplicons of fecal samples. Each ball represents the relative bacterial composition of one
fecal sample. No difference in gut microbiota composition was detected between HF casein (red balls) and HF whey (green balls) while the
composition significantly differed between high-fat and low-fat groups (LF casein, yellow balls) (P,0.05). HF casein, high-fat diet with casein, HF
whey, high-fat diet with whey protein isolate, LF casein, low-fat diet with casein.
doi:10.1371/journal.pone.0071439.g003
Metabolic Effects of Whey Protein in Mice
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whey compared to casein observed in this study. As our
experiment was designed to study the effects in a high-fat fed
model and therefore did not include a low-fat whey-group we
cannot rule out a potential interaction between whey and dietary
fat content.
In conclusion, whey significantly alleviated several conditions
associated with the metabolic syndrome in mice fed a high-fat diet.
The mechanisms behind the early reducing effect of whey on body
weight as well as the other metabolic effects remain to be studied
further.
Materials and Methods
Ethics Statement
The study design was approved by the National Committee for
Animal Experimentation, Ministry of Justice, Copenhagen, Den-
mark (License Number: 2007/561-1434 C1).
Experimental design
40 male C57BL/6NTac mice (Taconic, Laven, Denmark) were
purchased at the age of three weeks and housed in groups of five
with free access to food and water. Temperature was maintained
at 20–24uC, the relative humidity was 55%610% and the light
was automatically switched off from 6 pm to 6 am. During two
weeks of acclimatization, all mice were fed an Altromin 1324
standard rodent diet (Brogaarden, Denmark). At the age of five
weeks, the cages were matched by body weight and divided into
three experimental groups (‘‘HF casein’’, ‘‘HF whey’’, and ‘‘LF
casein’’) to be fed a high-fat diet with casein, a high-fat diet with
whey protein isolate, and a low-fat control diet with casein,
respectively, as described below. The groups were fed the
respective test diets for 14 weeks. Body weights were recorded
weekly and food intake was recorded twice weekly.
Test diets
The HF casein group and the LF casein group were fed the
widely used casein-based D12492 and D12450B with 60%,
respectively 10%, of energy from fat (Research Diets Inc., New
Brunswick, NJ, USA). The HF whey group received a high-fat diet
similar to HF casein except for the protein source which was
replaced with whey protein isolate (custom made based upon
D12492 by Research Diets) (Table 4). The whey protein isolate
consisted of undenatured soluble whey proteins processed by ion
exchange and ultrafiltration (NZMP, New Zealand). Amino acid
profiles of both protein sources are listed in Table S1.
Fecal sampling and analyses
At week 0, 7, and 13 weeks fecal pellets were collected in
autoclaved micro tubes (Brand, Wertheim, Germany) immediately
after defecation. If the mouse did not defecate spontaneously when
restrained it was kept in a clean cage until defecation. The samples
were initially kept on ice and subsequently stored at 280uC until
further analyses. DNA extraction, Polymerase Chain Reaction
(PCR), denaturing gradient gel electrophoresis (DGGE), and data
analyses were performed as previously described [39]. In brief,
bacterial DNA was extracted using the QIAamp DNA Stool Mini
Kit (Qiagen, Hilden, Germany). Quality and concentration of the
extracted DNA was verified on a NanoDrop 1000 Spectropho-
tometer (Thermo Scientific, USA). Genetic material was then
amplified by PCR, using primers specific to the V3 region of the
16S rRNA gene and genetic material was separated by means of
DGGE on a polyacrylamid gel containing a 30%–65% denaturing
Table 4. Detailed diet compositiona of the three experimental groups.
Group and product code HF casein (D12492) HF whey (D10082504) LF casein (D12450B)
Casein, 30 Mesh (g) 200 0 200
Whey protein isolateb (g) 0 189 0
L-Cystine (g) 3 3 3
Corn Starch (g) 0 0 315
Maltodextrin 10 (g) 125 125 35
Sucrose (g) 68.8 68.8 350
Cellulose, BW 200 (g) 50 50 50
Soybean Oil (g) 25 25 25
Lard (g) 245 245 20
Mineral Mix S10026 (g) 10 10 10
DiCalcium Phosphate (g) 13 13 13
Calcium Carbonate (g) 5.5 5.5 5.5
Potassium Citrate, 1H2O (g) 16.5 16.5 16.5
Vitamin Mix V10001 (g) 10 10 10
Choline Bitartrate (g) 2 2 2
Energy (kJ/g) 21.4 21.4 15.5
Protein (kJ%) 18 18 18
Carbohydrate (kJ%) 20 20 71
Fat (kJ%) 62 62 10
aDiets were formulated and produced by Research Diets Inc. (New Brunswick, NJ, USA).
bAlacen 895, NZMP, New Zealand.
doi:10.1371/journal.pone.0071439.t004
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gradient (100% corresponds to 7 M urea and 40% formamide).
The DGGE is further explained in Figure S1.
Oral glucose tolerance test and HbA1c
An oral glucose tolerance test (OGTT) was performed after 12
weeks of diet intervention. After an overnight fast (10 hours) the
mice were gavaged orally with a glucose solution of 2 mg glucose/
g body weight, and blood glucose was measured before dosing and
after 30, 60, 90, 120, and 180 minutes using Freestyle Mini
Glucometer (Hermedico, Copenhagen, Denmark). At week 13,
HbA1c was measured on a Siemens DCA Vantage Analyzer
(Siemens Healthcare Diagnostics, Ballerup, Denmark) by trans-
ferring 1 ml full blood from a tail vein puncture to the supplied
collection cassette.
Blood sampling and tissue collection
After 14 weeks of diet intervention, the mice were anesthetised
with a Hypnorm/Dormicum mixture (Hypnorm: 0.315 mg/ml
Fentanyl, 10 mg/ml Fluanisone; VetaPharma Ltd, Leeds, UK.
Dormicum: 5 mg/ml Midazolam; Roche A/S, Hvidovre, Den-
mark) injected subcutaneously as a 1:1:2 sterile water solution
(0.006 ml/g body weight) after an overnight fast (10 hours). Blood
was collected from the periorbital plexus in EDTA coated micro
tubes (Milian, Geneva, Switzerland) and immediately centrifuged
for plasma. The mice were killed by cervical dislocation. Liver,
fatty and muscular tissues were weighed and kept on dry ice until
storage at 280uC or fixated in formalin for future studies.
Plasma analyses
Plasma glucose, cholesterol, non-esterified fatty acids and
triacylglycerols were analysed on an automatic analyser (Cobas
Mira Plus, Roche Diagnostics, Hvidovre, Denmark) using reagents
from Horiba ABX (Montpellier Cedex 4, France). Plasma insulin
was measured by a commercial mouse ELISA kit (Mercodia,
Uppsala, Sweden). The QUICKI index was calculated based on
the logarithmic transformation: 1/(log insulin [mU/ml]+log
glucose [mg/dl]).
Statistics
Results are presented as mean 6SEM unless otherwise stated.
The Prism software package (Version 5.02, GraphPad Software
Inc., San Diego, CA, USA) and SAS Analyst (Version 9.2, SAS
Institute Inc., Cary, NC, USA) were used to manage and
statistically analyse the data. Experimental groups were compared
by one-way ANOVA and Tukey’s Post Hoc test. For the OGTT,
both one-way ANOVA on area under the curve (AUC)
calculations and Repeated Measurements ANOVA with Tukey’s
Post Hoc test were applied. When relevant, data (glucose, insulin)
was log transformed to normality. DGGE profiles were analysed
for clustering by Dice similarity coefficient with a band position
tolerance and optimization of 1% using the Unweighted Pair
Group Method with Arithmetic averages clustering algorithm
(UPGMA) and Principal Component Analysis (PCA) (BioNu-
merics, Version 4.5, Applied Maths, Sint-Martens-Latem, Bel-
gium) as previously described [39]. The significance level was set
at 0.05.
Supporting Information
Figure S1 Cluster analysis similarity tree of fecal
microbiota. Dendrogram of DGGE profiles representing 16S
rRNA gene-derived amplicons of fecal samples collected from
C57BL/6 mice fed high-fat diet with casein (red circles), high-fat
diet with whey (green circles) and low-fat diet with casein (yellow
circles), respectively, for 13 weeks. Each horizontal lane represents
one fecal sample (indicated by an arrow) and each band (black
line) on a lane represents in principle one bacterial species. The
larger the distance between two samples in the dendogram the
more different their compositions are. The mice clustered strongly
after gel which was included as a factor in the statistical analysis.
Principal Component Analysis revealed a significantly different
clustering between high- and low fat groups (P,0.05) demon-
strating different fecal microbial composition while there was no
effect of protein source. DGGE, denaturing gradient gel
electrophoresis.
(PDF)
Table S1 Amino acid profile of casein and whey protein.
(DOCX)
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